Nesfatin-1 as a novel cardiac peptide: Identification, functional characterization, and protection against ischemia/reperfusion injury

Cellular and Molecular Life Sciences

Volumn 70, Issue 3, 2013, Pages 495-509

  Angelone, T ^a   Filice, E ^a   Pasqua, T ^a   Amodio, N ^b   Galluccio, M ^a   Montesanti, G ^a   Quintieri, A M ^a   Cerra, M C ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Cardioprotection; Natriuretic peptide receptor A; Nesfatin 1; PGC PKG; Signal transduction

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; LACTATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATRIURETIC PEPTIDE RECEPTOR A; NESFATIN 1; NITRIC OXIDE; NUCLEOBINDIN 2; PEPTIDE DERIVATIVE; POTASSIUM CHANNEL; PROTEIN KINASE C EPSILON; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME RELEASE; HEART CONTRACTION; HEART INFARCTION SIZE; HEART MUSCLE RELAXATION; HEART PROTECTION; ISOLATED HEART; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REPERFUSION INJURY;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM-BINDING PROTEINS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; KATP CHANNELS; L-LACTATE DEHYDROGENASE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; NERVE TISSUE PROTEINS; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REPERFUSION INJURY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84872329989     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1138-7     Document Type: Article

References (49)

1. Angelone T, Quintieri AM, Amodio N, Cerra MC (2011) Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic control. Curr Med Chem 18(32):4976-4986
2. Vona-Davis LC, McFadden DW (2007) NPY family of hormones: clinical relevance and potential use in gastrointestinal disease. Curr Top Med Chem 7(17):1710-1720
3. Pedrazzini T, Seydoux J, Künstner P, Aubert JF, Grouzmann E, Beermann F, Brunner HR (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4(6):722-726
4. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443(7112):709-712
5. Elmquist JK, Coppari R, Balthasar N, Ichinose M, Lowell BB (2005) Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 493(1):63-71
6. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, Lambrecht NW (2009) Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150(1): 232-238
7. Su Y, Zhang J, Tang Y, Bi F, Liu JN (2010) The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 391(1):1039-1042
8. Price TO, Samson WK, Niehoff ML, Banks WA (2007) Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 28(12):2372-2381
9. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ (2007) Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148(10): 5088-5094
10. Pałasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, Bajor G (2012) Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides http://dx.doi.org/ 10.1016/j.npep.2011.12.002
11. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T (2009) Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 10(5):355-365
12. Mimee A, Smith PM, Ferguson AV (2012) Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function. Am J Physiol Regul Integr Comp Physiol. doi:10.1152/ajpregu.00266.2011
13. Yosten GL, Samson WK (2009) Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 297(2): R330-R336
14. Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res Cardiol 101(1):43-52
15. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M (2009) Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150(2):662-671
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-C(T)) method. Methods 25:402-408
17. Cerra MC, Angelone T, Parisella ML, Pellegrino D, Tota B (2009) Nitrite modulates contractility of teleost (Anguilla anguilla and Chionodraco hamatus, i.e. the Antarctic hemoglobinless icefish) and frog (Rana esculenta) hearts. Biochim Biophys Acta 1787(7):849-855
18. Angelone T, Goumon Y, Cerra MC, Metz-Boutigue MH, Aunis D, Tota B (2006) The emerging cardioinhibitory role of the hippocampal cholinergic neurostimulating peptide. J Pharmacol Exp Ther 318(1):336-344
19. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N (2003) Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34(1):33-43
20. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P (2007) Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 75(1):168-177
21. + channel and protein kinase C activation. Basic Res Cardiol 101(2): 180-189
22. Parat M, McNicoll N, Wilkes B, Fournier A, De Léan A (2008) Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A. Mol Pharmacol 73(2):431-440
23. Springer J, Azer J, Hua R, Robbins C, Adamczyk A, McBoyle S, Bissell MB, Rose RA (2012) The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. J Mol Cell Cardiol http://dx.doi.org/10.1016/ j.yjmcc.2012.01.018
24. Yamawaki H, Takahashi M, Mukohda M, Morita T, Okada M, Hara Y (2012) A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats. Biochem Biophys Res Commun 418(4):676-681
25. Angelone T, Filice E, Quintieri AM, Imbrogno S, Amodio N, Pasqua T, Pellegrino D, Mulè F, Cerra MC (2010) Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart. Nutr Metab Cardiovasc Dis http:// dx.doi.org/10.1016/j.numecd.2010.07.014
26. Yosten GL, Redlinger L, Samson WK (2012) Evidence for a role of endogenous nesfatin-1 in the control of water drinking. J Neuroendocrinol. doi:10.1111/j.1365-2826.2012.02304.x
27. Mohan H, Unniappan S (2012) Ontogenic pattern of nucleobindin-2/nesfatin- 1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats. Regul Pept 175(1-3): 61-69
28. Opie LH (2004) Heart physiology. From cell to circulation. 4th edn. Lippincott, Philadelphia
29. Sperelakis N, Kurachi Y, Terzic A, Cohen MV (2001) Heart physiology and pathophysiology, 4th edn. Academic, San Diego
30. Piascik MT, Perez DM (2001) Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298(2):403-410
31. + current in rat ventricular myocytes. J Physiol 531(Pt 1):117-130
32. Lin X, Hänze J, Heese F, Sodmann R, Rudolf E (1995) Lang gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 77:750-758
33. Potter LR, Abbey-Hosch S, Dickey DM (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphatedependent signaling functions. Endocr Rev 27(1):47-72
34. Dube′ PE, Forse CL, Bahrami J, Brubaker PL (2006) The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131:589-605
35. Clerk A, Sugden PH (2004) Signaling through the extracellular signal regulated kinase 1/2 cascade in cardiac myocytes. Biochem Cell Biol 82(6):603-609
36. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K (2005) Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 289(4):H1618-H1626
37. Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R, Corti A, Losano G, Cerra MC (2007) Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Am J Physiol Heart Circ Physiol 293(1):H719-H727
38. Penna C, Alloatti G, Gallo MP, Cerra MC, Levi R, Tullio F, Bassino E, Dolgetta S, Mahata SK, Tota B, Pagliaro P (2010) Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart. Cell Mol Neurobiol 30(8):1171-1179
39. Penna C, Abbadessa G, Mancardi D, Tullio F, Piccione F, Spaccamiglio A, Racca S, Pagliaro P (2008) Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2-adrenoceptor. J Physiol Pharmacol 59(4):645-659
40. Pagliaro P, Moro F, Tullio F, Perrelli MG, Penna C (2011) Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxid Redox Signal 14(5):833-850
41. Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14(5):893-907
42. Nishikimi T, Maeda N, Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 9(2):318-328
43. Bolli R, Dawn B, Xuan YT (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 13:72-79
44. Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, Sack MN, Jonassen AK, Mjøs OD, Opie LH, Lecour S (2008) Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol 103:444-453
45. Mascareno E, El-Shafei M, Maulik N, Sato M, Guo Y, Das DK, Siddiqui MA (2001) JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104:325-329
46. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105:771-785
47. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R (2001) An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA 98:9050-9055
48. Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61:448-460
49. Penna C, Abbadessa G, Mancardi D, Spaccamiglio A, Racca S, Pagliaro P (2007) Nandrolone-pretreatment enhances cardiac beta(2)-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats. J Steroid Biochem Mol Biol 107(1-2):106-113